Delphine Hajaji has 14 years of Digital and Tech experience across various industries, the past seven of which are in pharma. Between 2012-2019 Delphine was responsible for the data and technology strategy and implementation of all non-drug solutions at UCB: biosensors, e-devices, diagnostic tools, and companion apps. In addition, she has been responsible for the strategy & implementation of several global multichannel campaigns at UCB and in previous roles at other pharma companies (GSK Vaccines, BMS EMEA, Pfizer EMEA).
Prior to UCB, as a management consultant, Delphine advised blue-chip European companies on how to thrive in a digital world: her scope encompassed business model innovation, operating model changes, and program management. Delphine Hajaji has an MBA from Vlerick Management School and a Master's degree in History from Ghent University. In her spare time, Delphine provides ad hoc advisory services to private equity firms in due diligence assessments for tech start-ups looking for seed financing. Delphine also enjoys attending theatre and dance performances and practicing the violin with her two children.